Gilead withdraws use of Zydelig to treat cancer
Synopsis : The US FDA gave the drug an accelerated approval to treat relapsed follicular B-cell non-Hodgkin lymphoma and relapsed small lymphocytic…
Synopsis : The US FDA gave the drug an accelerated approval to treat relapsed follicular B-cell non-Hodgkin lymphoma and relapsed small lymphocytic…
An SPC cannot be granted for a medicinal product which is protected in the basic patent and already on the market –…